Basit öğe kaydını göster

dc.contributor.authorSumnu, Abdullah
dc.contributor.authorKAZANCIOĞLU, Rümeyza
dc.contributor.authorUzun, Sami
dc.contributor.authorDoventas, Yasemin
dc.contributor.authorOzturk, Savaş
dc.contributor.authorAydin, Zeki
dc.contributor.authorGursu, Meltem
dc.contributor.authorKaradag, Serhat
dc.date.accessioned2021-03-08T16:24:52Z
dc.date.available2021-03-08T16:24:52Z
dc.date.issued2014
dc.identifier.citationAydin Z., Gursu M., Karadag S., Uzun S., Sumnu A., Doventas Y., Ozturk S., KAZANCIOĞLU R., "The relationship of Prohepcidin levels with anemia and inflammatory markers in non-diabetic uremic patients: a controlled study", RENAL FAILURE, cilt.36, sa.8, ss.1253-1257, 2014
dc.identifier.issn0886-022X
dc.identifier.othervv_1032021
dc.identifier.otherav_816284a9-0915-425c-aace-e0383058ea7c
dc.identifier.urihttp://hdl.handle.net/20.500.12627/167678
dc.identifier.urihttps://doi.org/10.3109/0886022x.2014.937663
dc.description.abstractIntroduction: Hepcidin, a small peptide hormone synthesized in the liver, plays central role in regulation of iron metabolism. Hepcidin generation in chronic kidney disease (CKD) is dependent on iron status, anemia, inflammation, and hypoxia and erythropoietin levels. In our study, the relationship between Prohepcidin levels and inflammation and iron indices in non-diabetic uremic patients was investigated. Methods: This study has a cross-sectional design which includes four groups: Non-diabetic 21 patients with stage 4 CKD (predialysis), 20 hemodialysis (HD) and 21 peritoneal dialysis (PD) patients and 17 healthy volunteers as the control group. Complete blood count, iron, total iron binding capacity (TIBC), ferritin, high-sensitive C-reactive protein (hsCRP), fibrinogen, parathyroid hormone, interleukin (IL)-6 and Prohepcidin levels were recorded. Results: Serum Prohepcidin levels in the predialysis, HD, PD and the control groups were 119.6 +/- 45.1 ng/mL, 140.2 +/- 41.8 ng/mL, 148.2 +/- 35.0 ng/mL and 93.8 +/- 21.9 ng/mL, respectively (p<0.001). Prohepcidin was positively correlated with urea (r = 0.345, p = 0.002), creatinine (r = 0.465, p<0.001), phosphorus (r = 0.253, p = 0.025), hsCRP (r = 0.275, p = 0.019), duration of dialysis treatment (r = 0.443, p<0.001), fibrinogen (r = 0.467, p<0.001) and IL-6 (r = 0.615, p<0.001) levels. A negative correlation was detected between Prohepcidin levels and albumin (r = -0.286, p<0.001), TIBC (r = -0.573, p<0.001), GFR (r = -0.473, p<0.001), hemoglobin (r = -0.351, p = 0.002) and hematocrit (r = -0.342, p = 0.002) levels. Discussion: Prohepcidin levels increase with deepening anemia and show positive correlation with inflammatory markers. Therapeutic interventions regarding Prohepcidin action on inflammatory status may play a role in the treatment of anemia due to inflammation. Functional iron deficiency is frequent in uremic patients. It may be beneficial to measure Prohepcidin level together with ferritin among these patients.
dc.language.isoeng
dc.subjectNephrology
dc.subjectUrology
dc.subjectHealth Sciences
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectNefroloji
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectÜROLOJİ VE NEFROLOJİ
dc.titleThe relationship of Prohepcidin levels with anemia and inflammatory markers in non-diabetic uremic patients: a controlled study
dc.typeMakale
dc.relation.journalRENAL FAILURE
dc.contributor.departmentIstanbul Haseki Training & Research Hospital , ,
dc.identifier.volume36
dc.identifier.issue8
dc.identifier.startpage1253
dc.identifier.endpage1257
dc.contributor.firstauthorID2528765


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster